Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Grünenthal Ltd, Regus Lakeside House, 1 Furzeground Way, Stockley Park East, Uxbridge, Middlesex, UB11 1BD, UK
Zomig 5 mg Nasal Spray.
| Pharmaceutical Form |
|---|
|
Nasal Spray. |
Zomig Nasal Spray is an aqueous solution containing 50 mg/ml zolmitriptan, buffered to pH 5.0. The device delivers a unit dose of 5 mg and is intended for a single use only.
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zolmitriptan |
Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors. |
| List of Excipients |
|---|
|
Each Zomig Nasal Spray vial contains the following excipients: Citric acid |
Ph Eur Type I glass vials which are closed with chlorobutyl rubber stoppers. The vials are assembled into a unit dose nasal spray device, comprising of a vial holder, an actuation device and a protection cover.
Packs containing 1, 2, or 6 single use devices.
Not all pack sizes may be marketed.
Grünenthal Ltd, Regus Lakeside House, 1 Furzeground Way, Stockley Park East, Uxbridge, Middlesex, UB11 1BD, UK
PL 21727/0085
Date of first authorisation: 19th September 2002
Date of latest renewal: 18th June 2008
| Drug | Countries | |
|---|---|---|
| ZOMIG | Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
